Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that its Board of Directors has appointed Mario Alberto Accardi PhD, President and founder of ...

Hole K-25-277: The hole was drilled northwest on 300° azimuth at a -60° dip to a depth of 159 metres. The main purpose of the ...

HIGHLIGHTS Assays confirm uranium mineralization across the Mineralized RIB Corridor (“MRC”) at RIB South, East and West ...

Herrington Management, a digital media company specializing in research-driven publishing and consumer insights, has released a comprehensive editorial brief examining the redemption value of ...

Canadian Metals Inc. (CSE: CME) ("CME" or the "Company") is pleased to announce the commencement of ~3,200-metre drill ...

Objective To examine household-level patterns of self-reliance among forcibly displaced and host populations using the ...

Elements of President Donald Trump’s envisioned air and missile defense shield emerged at this weekend’s Reagan National ...

Seattle's plans to celebrate its LGBTQ+ community coincide with a group-stage fixture between two countries that criminalize ...

Sacituzumab does not improve outcomes vs chemotherapy when used as the first treatment after endocrine therapy failure in HR+/HER2- advanced breast cancer, the ASCENT-07 trial finds.

The City of Del Mar has commissioned updated feasibility studies of three potential sites for affordable housing at the ...

In our 2025 edition of Pro Bono Innovators, Bloomberg Law honors Davis Wright Tremaine for its work on behalf of children in ...

New two- and three-year EPCORE® NHL-2 follow-up data evaluating epcoritamab in combination with standard of care regimens demonstrate remission in patients with DLBCL and FLLatest EPCORE DLBCL-3 trial ...